Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Steinhoff

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Clinical EEG (Electroencephalography)|January 1, 1993
Transcranial magnetic stimulation (TMS) of the brain in patients with mesiotemporal epileptic fociB J Steinhoff, S R Stodieck, Z Zivcec, et al.
Journal of Neurology|January 20, 2017
Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studiesS D Shorvon, E Trinka, B J Steinhoff, et al.
Der Nervenarzt|August 2, 2012
[Slow release versus immediate release oxcarbazepine in difficult-to-treat focal epilepsy: a multicenter, randomized, open, controlled, parallel group phase III study]B J Steinhoff, H Stefan, A Schulze-Bonhage, et al.
Epilepsia|August 8, 2001
Unsuspected atypical hemispheric dominance for language as determined by fMRIJ Spreer, A Quiske, D M Altenmüller, et al.
Epilepsia|December 13, 2000
Source reconstruction of mesial-temporal epileptiform activity: comparison of inverse techniquesT D Waberski, R Gobbelé, G Herrendorf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 8, 2007
Factors influencing surgical outcome in patients with focal cortical dysplasiaS Fauser, T Bast, D-M Altenmüller, et al.
Acta Neurologica Scandinavica|July 23, 2016
Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational studyE Schmid, G Kuchukhidze, M Kirschner, et al.
Epilepsy Research|August 27, 1999
Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsyB J Steinhoff, H Tumani, M Otto, et al.
Archives of Neurology|January 29, 1999
The Heidenhain variant of Creutzfeldt-Jakob diseaseS Kropp, W J Schulz-Schaeffer, M Finkenstaedt, et al.
Neurology|September 6, 2007
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity modelD G A Kasteleijn-Nolst Trenité, P Genton, D Parain, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Clinical EEG (Electroencephalography)|January 1, 1993
Transcranial magnetic stimulation (TMS) of the brain in patients with mesiotemporal epileptic fociB J Steinhoff, S R Stodieck, Z Zivcec, et al.
Journal of Neurology|January 20, 2017
Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studiesS D Shorvon, E Trinka, B J Steinhoff, et al.
Der Nervenarzt|August 2, 2012
[Slow release versus immediate release oxcarbazepine in difficult-to-treat focal epilepsy: a multicenter, randomized, open, controlled, parallel group phase III study]B J Steinhoff, H Stefan, A Schulze-Bonhage, et al.
Epilepsia|August 8, 2001
Unsuspected atypical hemispheric dominance for language as determined by fMRIJ Spreer, A Quiske, D M Altenmüller, et al.
Epilepsia|December 13, 2000
Source reconstruction of mesial-temporal epileptiform activity: comparison of inverse techniquesT D Waberski, R Gobbelé, G Herrendorf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 8, 2007
Factors influencing surgical outcome in patients with focal cortical dysplasiaS Fauser, T Bast, D-M Altenmüller, et al.
Acta Neurologica Scandinavica|July 23, 2016
Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational studyE Schmid, G Kuchukhidze, M Kirschner, et al.
Epilepsy Research|August 27, 1999
Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsyB J Steinhoff, H Tumani, M Otto, et al.
Archives of Neurology|January 29, 1999
The Heidenhain variant of Creutzfeldt-Jakob diseaseS Kropp, W J Schulz-Schaeffer, M Finkenstaedt, et al.
Neurology|September 6, 2007
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity modelD G A Kasteleijn-Nolst Trenité, P Genton, D Parain, et al.
Pageof 9